Drug Discovery and Development: W. L. Gore & Associates, Inc.

• Publication date: March 2012

This report is a source for data, analysis and actionable intelligence on the W. L. Gore & Associates, Inc. portfolio of new product development . The report provides detailed analysis on each pipeline product with data on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date. Each pipeline product is profiled to cover data on product descript...

This report is a source for data, analysis and actionable intelligence on the W. L. Gore & Associates, Inc. portfolio of new product development . The report provides detailed analysis on each pipeline product with data on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.

Each pipeline product is profiled to cover data on product description, function, technology, indication, and application. The report is also supplemented with a detailed industry player profile and data on clinical trials, wherever applicable.

Scope of the Research

- Detailed industry player profile with data on business description, key industry player facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
- Detailed coverage on all the new product development, by equipment type, by therapy area, by development stage, and by trial phase.
- Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
- Profile of each pipeline product with additional data on product description, function, technology, indication(s), and application.
- Data on relevant clinical trials and product patent details, wherever applicable.
- Information on clinical trial, wherever applicable, is supplemented with data on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
- Design and develop your product development, industry ing and sales strategies.
- Exploit Merger and Acquisition opportunities by identifying industry players with the most innovative pipeline.
- Develop successful market-entry strategies .
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Develop competition strategies by identifying the status and likely launch of your competitors’ new product development through review of the clinical trials, stage and phase of development, etc.
- Which are the next high-value products that your competitor would add in its portfolio? – identify, understand and capitalize.

Blood Supply, Tissue Banking And Transplantation Industry in Australia

Data table of Contents
Data table of Contents 2
List of Tables 3
List of Figures 4
W. L. Gore & Associates, Inc. - Business Overview 5
Key Facts 6
W. L. Gore & Associates, Inc. - Major Products and Services 7
W. L. Gore & Associates, Inc. Pipeline Products by Equipment Type 10
W. L. Gore & Associates, Inc. Pipeline Products by Development Stage 12
W. L. Gore & Associates, Inc. Pipeline Products by Therapy Area 13
W. L. Gore & Associates, Inc. Pipeline Products by Trial Phase 14
W. L. Gore & Associates, Inc. Pipeline Products by Milestone Summary 15
GORE ACUSEAL Vascular Graft 16
Product Status 16
Product Description 16
Product Milestone 16
GORE ACUSEAL Vascular Graft Clinical Trial 17
GORE Embolic Filter 17
Product Status 18
Product Description 18
Product Milestone 18
GORE Embolic Filter Clinical Trial 18
GORE HELEX September tal Occluder - PFO 19
Product Status 19
Product Description 19
Product Milestone 19
GORE HELEX September tal Occluder - PFO Clinical Trial 20
Product Patent Details 23
GORE VIABIL Biliary Endoprosthesis 23
Product Status 23
Product Description 23
Product Milestone 23
Next Generation Conformable GORE TAG Device - Acute Complicated Type B Dissection 24
Product Status 24
Product Description 24
Next generation Conformable GORE TAG Thoracic Endoprosthesis - Thoracic Aortic Aneurysm 24
Product Status 24
Product Description 25
Product Milestone 25
Next Generation Conformable GORE TAG Thoracic Endoprosthesis Device - Traumatic Aortic Transection 26
Product Status 26
Product Description 26
W. L. Gore & Associates, Inc. - Top Competitors 27
W. L. Gore & Associates, Inc. - Key Executives 28
W. L. Gore & Associates, Inc. - Operations and Subsidiaries 29
Head Office 29
Other Locations & Subsidiaries 29
Recent Developments 31
December 08, 2010: Vulcan Minerals Provides Western Newfoundland Operations Update 31
November 19, 2010: Gore Sponsors EVEResT Endovascular Research Simulation Symposium 31
August 24, 2010: AGA Medical Sues W.L. Gore & Associates For Patent Infringement 32
Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33


List of Tables

W. L. Gore & Associates, Inc., Major development 1
W. L. Gore & Associates, Inc. Key Pipeline Products by Equipment Type 1
W. L. Gore & Associates, Inc. Key Pipeline Products by Therapy Area 1
W. L. Gore & Associates, Inc. Key Pipeline Products by Development Stage 1
W. L. Gore & Associates, Inc. Key Pipeline Products by Trial Phase 1
W. L. Gore & Associates, Inc., Major development 6
W. L. Gore & Associates, Inc., Major Products and Services 7
W. L. Gore & Associates, Inc. Number of Pipeline Products by Equipment Type 10
W. L. Gore & Associates, Inc. Pipeline Products by Equipment Type 11
W. L. Gore & Associates, Inc. Number of Pipeline Products by Development Stage 12
W. L. Gore & Associates, Inc. Pipeline Products by Development Stage 12
W. L. Gore & Associates, Inc. Number of Pipeline Products by Therapy Area 13
W. L. Gore & Associates, Inc. Pipeline Products by Therapy Area 13
W. L. Gore & Associates, Inc. Number of Pipeline Products by Trial Phase 14
W. L. Gore & Associates, Inc. Pipeline Products by Trial Phase 14
W. L. Gore & Associates, Inc. Number of Pipeline Products By Milestone Summary 15
W. L. Gore & Associates, Inc. Pipeline Products by Milestone Summary 15
GORE ACUSEAL Vascular Graft - Product Status 16
GORE ACUSEAL Vascular Graft - Product Description 16
GORE ACUSEAL Vascular Graft - Product Milestone 16
GORE ACUSEAL Vascular Graft - Evaluation of the GORE ACUSEAL Vascular Graft for Hemodialysis Access (ACUSEAL, AVG 08-06) 17
GORE Embolic Filter - Product Status 18
GORE Embolic Filter - Product Description 18
GORE Embolic Filter - Product Milestone 18
GORE Embolic Filter - EMBOLDEN Clinical Study 18
GORE HELEX September tal Occluder - PFO - Product Status 19
GORE HELEX September tal Occluder - PFO - Product Description 19
GORE HELEX September tal Occluder - PFO - Product Milestone 19
GORE HELEX September tal Occluder - PFO - GORE HELEX September tal Occluder And Antiplatelet Medical Management For Reduction Of Recurrent Stroke Or Imaging-Confirmed TIA In Patients With Patent Foramen Ovale (PFO) 20
GORE HELEX September tal Occluder - PFO - GORE HELEX September tal Occluder Post-Approval Study 21
GORE HELEX September tal Occluder - PFO - A study to close a common hole found in the heart called a patent foramen ovale (PFO) in order to prevent recurrent strokes and transient ischemic attacks (TIAs) in adults. 21
GORE HELEX September tal Occluder - PFO - Nickel Allergy With September tal Occluder Using Amplatzer and Helex Devices (NASAH) Trial 22
GORE HELEX September tal Occluder - PFO - Patent Details 23
GORE VIABIL Biliary Endoprosthesis - Product Status 23
GORE VIABIL Biliary Endoprosthesis - Product Description 23
GORE VIABIL Biliary Endoprosthesis - Product Milestone 24
Next Generation Conformable GORE TAG Device - Acute Complicated Type B Dissection - Product Status 24
Next Generation Conformable GORE TAG Device - Acute Complicated Type B Dissection - Product Description 24
Next generation Conformable GORE TAG Thoracic Endoprosthesis - Thoracic Aortic Aneurysm - Product Status 24
Next generation Conformable GORE TAG Thoracic Endoprosthesis - Thoracic Aortic Aneurysm - Product Description 25
Next generation Conformable GORE TAG Thoracic Endoprosthesis - Thoracic Aortic Aneurysm - Product Milestone 25
Next Generation Conformable GORE TAG Thoracic Endoprosthesis Device - Traumatic Aortic Transection - Product Status 26
Next Generation Conformable GORE TAG Thoracic Endoprosthesis Device - Traumatic Aortic Transection - Product Description 26
W. L. Gore & Associates, Inc., Key Executives 28
W. L. Gore & Associates, Inc., Other Locations 29
W. L. Gore & Associates, Inc., Subsidiaries 30


List of Figures

W. L. Gore & Associates, Inc. Key Pipeline Products by Equipment Type 1
W. L. Gore & Associates, Inc. Pipeline Products by Equipment Type 10
W. L. Gore & Associates, Inc. Pipeline Products by Development Stage 12
W. L. Gore & Associates, Inc. Pipeline Products by Therapy Area 13
W. L. Gore & Associates, Inc. Pipeline Products by Trial Phase 14
W. L. Gore & Associates, Inc. Pipeline Products by Milestone Summary 15

Companies mentioned Medtronic, Inc.
Lombard Medical Technologies PLC
LeMaitre Vascular, Inc.
Cordis Corporation
Endologix, Inc.
Aptus Endosystems, Inc.
Cook Medical Incorporated